Patterns and predictors of opioid use among migraine patients at emergency departments: A retrospective database analysis
暂无分享,去创建一个
[1] M. Shibata,et al. [Medication-overuse headache]. , 2020, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.
[2] Ivy Shiue,et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.
[3] S. Joukar,et al. Opioids and Cardiac Arrhythmia: A Literature Review , 2018, Medical Principles and Practice.
[4] J. Pavlović,et al. Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms , 2018, Headache.
[5] M. Bonafede,et al. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States , 2018, Headache.
[6] E. Loder,et al. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies , 2018, Headache.
[7] J. Finkelstein,et al. Multicenter prevalence of opioid medication use as abortive therapy in the ED treatment of migraine headaches , 2017, The American journal of emergency medicine.
[8] Craig M. Hales,et al. Hypertension Prevalence and Control Among Adults: United States, 2015-2016. , 2017, NCHS data brief.
[9] Heidi Moawad. Migraine and Depression: Is There a Link? , 2017 .
[10] Nancy E. Kelley,et al. Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies , 2016, Headache.
[11] D. Boomsma,et al. Genetic epidemiology of migraine and depression , 2016, Cephalalgia : an international journal of headache.
[12] M. Carroll,et al. Hypertension Prevalence and Control Among Adults: United States, 2011-2014. , 2015, NCHS data brief.
[13] L. Webster,et al. Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies. , 2015, Pain medicine.
[14] E. Gallagher,et al. Current management of migraine in US emergency departments: An analysis of the National Hospital Ambulatory Medical Care Survey* , 2015, Cephalalgia : an international journal of headache.
[15] S. Silberstein,et al. The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies , 2015, Headache.
[16] D. Turk,et al. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. , 2014, Pain medicine.
[17] R. Lipton,et al. Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study , 2012, Headache.
[18] S. Silberstein,et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.
[19] S. Pearlman,et al. Opioid Use and Dependence Among Persons With Migraine: Results of the AMPP Study , 2012, Headache.
[20] A. Elixhauser,et al. Headaches in U.S. Hospitals and Emergency Departments, 2008 , 2011 .
[21] R. Lipton,et al. Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study , 2010, Cephalalgia : an international journal of headache.
[22] R. Lipton,et al. Use of the Emergency Department for Severe Headache. A Population‐Based Study , 2009, Headache.
[23] W. Stewart,et al. Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study , 2008, Headache.
[24] J. -. Park,et al. Decreased number and function of endothelial progenitor cells in patients with migraine , 2008, Neurology.
[25] R. Lipton,et al. Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.
[26] R. Gilder,et al. A Comparison of a Fentanyl, Morphine, and Hydromorphone Patient-Controlled Intravenous Delivery for Acute Postoperative Analgesia: A Multicenter Study of Opioid-Induced Adverse Reactions , 2006 .
[27] R. Lipton,et al. Migraine: Epidemiology, Impact, and Risk Factors for Progression , 2005, Headache.
[28] Jes Olesen,et al. The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.
[29] B. Rasmussen. Epidemiology of Headache , 2001, Cephalalgia : an international journal of headache.
[30] R. Lipton,et al. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.
[31] K. Lunetta,et al. Implications of comorbidity and ascertainment bias for identifying disease genes. , 2000, American journal of medical genetics.
[32] B. Akpunonu,et al. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. , 1995, Annals of emergency medicine.
[33] W. Stewart,et al. Population variation in migraine prevalence: a meta-analysis. , 1995, Journal of clinical epidemiology.
[34] M. Arnold. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.
[35] S. Pulfrey,et al. Treatment of acute migraine in the emergency department. , 2014, Canadian family physician Medecin de famille canadien.
[36] W F Stewart,et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. , 1992, JAMA.